Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006
Are severity scores for community acquired pneumonia being used in secondary care and its impact on appropriateness of antibiotic therapy - a retrospective study Source: Eur Respir J 2004; 24: Suppl. 48, 187s Year: 2004
Long-term impact of DRIP score on antibiotic stewardship in patients with community acquired pneumonia Source: Virtual Congress 2021 – Pneumonia Year: 2021
Can improved outcomes be achieved when patients with community acquired pneumonia are managed in accordance with the national guidelines? Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Using quality improvement project to improve childhood asthma outcomes in low resource setting Source: Virtual Congress 2021 – Early-life infections, wheezing and asthma Year: 2021
Progress of quality indicator rates regarding treatment of patients hospitalized in Germany due to community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Optimising treatment policies and improvement of care: impact on outcome in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 617s Year: 2004
Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
How can we improve the management and outcome of pneumonia in the elderly? Source: Eur Respir J 2008; 32: 12-14 Year: 2008
Dissemination of clinical skills for better management of patients: nurse led ABG monitoring in respiratory patients and its impact on management Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007
Influence of medical comorbidities in patients with community acquired pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Viral and M. pneumoniae community acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010
The effect of community lung rehabilitation guidance on the quality of life of patients with COPD. Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018
Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008
Impact of a home-based rehabilitation program on functional respiratory parameters and quality of life in COPD patients Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021
The efficiency of international and national asthma guidelines in improvement of the process, quality, and outcome of patient care Source: Eur Respir J 2004; 24: Suppl. 48, 471s Year: 2004
Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007
The clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia of the 3rd group Source: Eur Respir J 2007; 30: Suppl. 51, 548s Year: 2007
The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020
The general evaluation of elderly patients with community acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004